المؤلفون: Kawasaki A; Ono Pharmaceutical Co., Ltd, 1-5, Dosho-machi 2-chome, Chuo-ku, Osaka, 541-8526, Japan. ak.kawasaki@ono-pharma.com., Hatake K; Department of Hematology, International University of Health and Welfare, Tokyo, Japan., Matsumura I; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka, Japan., Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan., Hoshino T; Ono Pharmaceutical Co., Ltd, 1-5, Dosho-machi 2-chome, Chuo-ku, Osaka, 541-8526, Japan., Akamatsu A; Ono Pharmaceutical Co., Ltd, 1-5, Dosho-machi 2-chome, Chuo-ku, Osaka, 541-8526, Japan., Kakuuchi A; Ono Pharmaceutical Co., Ltd, 1-5, Dosho-machi 2-chome, Chuo-ku, Osaka, 541-8526, Japan., Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 667-676. Date of Electronic Publication: 2024 Mar 23.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Nivolumab*/adverse effects , Nivolumab*/therapeutic use , Nivolumab*/administration & dosage , Hodgkin Disease*/drug therapy , Product Surveillance, Postmarketing*, Humans ; Male ; Middle Aged ; Female ; Aged ; Japan/epidemiology ; Adult ; Prospective Studies ; Treatment Outcome ; Aged, 80 and over ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Agents, Immunological/therapeutic use ; Young Adult

المؤلفون: Takizawa J; Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan. juntaki@med.niigata-u.ac.jp., Suzuki R; Shimane University Hospital, Cancer Center, Izumo, Japan.; Department of Hematology and Oncology, Shimane University School of Medicine, Izumo, Japan., Izutsu K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan., Kiguchi T; Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan.; Division of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan., Asaoku H; Department of Hematology, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, Japan., Saburi Y; Department of Hematology, Oita Prefectural Hospital, Oita, Japan., Masunari T; Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan., Utsunomiya A; Department of Hematology, Imamura General Hospital, Kagoshima, Japan., Takeuchi K; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Nakamura N; Department of Pathology, Tokai University, Isehara, Japan., Ohshima K; Department of Pathology, Kurume University, Kurume, Japan., Gruber M; Department of Internal Medicine 1, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Jäger U; Department of Internal Medicine 1, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Aoki S; Pathophysiology, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan., Suzumiya J; Shimane University Hospital, Cancer Center, Izumo, Japan.; Department of Hematology, Koga Community Hospital, Shizuoka, Japan.

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 686-696. Date of Electronic Publication: 2024 Mar 16.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/genetics , Leukemia, Lymphocytic, Chronic, B-Cell*/epidemiology , Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis , Immunophenotyping*, Humans ; Japan/epidemiology ; Aged ; Male ; Female ; Middle Aged ; Aged, 80 and over ; Prospective Studies ; Adult ; Mutation ; Immunoglobulin Heavy Chains/genetics ; Immunoglobulin Variable Region/genetics

المؤلفون: Kato K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. kato.koji.429@m.kyushu-u.ac.jp., Izutsu K; Department of Hematology, Toranomon Hospital, Tokyo, Japan., Nishikori M; Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Shibayama H; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Maeda Y; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan., Yoshimura K; Innovative Clinical Research Centre, Kanazawa University Graduate School of Medicine, Kanazawa, Japan., Tateishi U; Department of Diagnostic Radiology, Tokyo Medical and Dental University, Tokyo, Japan., Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan., Matsuda Y; Cancer Care Promotion Center, University of Fukui Hospital, Fukui, Japan., Ishikawa J; Department of Hematology, Osaka International Centre Institute, Osaka, Japan., Rai S; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka, Japan., Takahashi T; Department of Hematology, Shimane University Hospital, Shimane, Japan., Yamauchi T; Department of Hematology and Oncology, University of Fukui, Fukui, Japan., Matsumura I; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka, Japan., Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan., Kanakura Y; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Suzumiya J; Department of Hematology, Koga Community Hospital, Daikakuji 2-30-1, Yaizu, Shizuoka, 425-0088, Japan. junji8suzumiya@gmail.com.

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 677-685. Date of Electronic Publication: 2024 Mar 22.

نوع المنشور: Journal Article; Multicenter Study; Clinical Trial, Phase II

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Follicular*/drug therapy , Lymphoma, Follicular*/diagnostic imaging , Lymphoma, Follicular*/mortality , Bendamustine Hydrochloride*/administration & dosage , Rituximab*/administration & dosage , Fluorodeoxyglucose F18*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Disease Progression* , Positron-Emission Tomography*/methods, Humans ; Middle Aged ; Aged ; Male ; Female ; Prospective Studies ; Adult ; Japan ; Recurrence ; Aged, 80 and over ; Radiopharmaceuticals/administration & dosage

المؤلفون: Sano H; Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Higashi-Sapporo 6-6, Shiroishi-ku, Sapporo, 003-0006, Japan. hirozumi.sano@gmail.com., Fukushima K; Department of Pediatrics, Dokkyo Medical University, Mibu, Japan., Yano M; Department of Pediatrics, Akita University Graduate School of Medicine, Akita, Japan., Osone S; Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kato Y; Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan., Hasegawa D; Department of Hematology/Oncology, Kobe Children's Hospital, Kobe, Japan., Miyamura T; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan., Iwamoto S; Department of Pediatrics, Mie University, Tsu, Japan., Takahashi H; Department of Pediatrics, Toho University, Tokyo, Japan., Terui K; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Tawa A; Higashiosaka Aramoto Heiwa Clinic, Higashiosaka, Japan., Tomizawa D; Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 745-754. Date of Electronic Publication: 2024 Mar 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Body Mass Index* , Overweight*/complications, Humans ; Child ; Male ; Female ; Japan/epidemiology ; Child, Preschool ; Adolescent ; Obesity/complications ; Infant ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; East Asian People

المؤلفون: Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan., Kameda T; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Kawano N; Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan., Ito T; First Department of Internal Medicine, Kansai Medical University, Osaka, Japan., Hashimoto Y; Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan., Shide K; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Kawano H; Koga General Hospital, Miyazaki, Japan., Sekine M; Koga General Hospital, Miyazaki, Japan., Toyama T; Miyazaki Prefectural Nobeoka Hospital, Nobeoka, Japan., Iizuka H; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan., Sato S; Miyakonojo Medical Center, Miyakonojo, Japan., Takeuchi M; Aisenkai Nichinan Hospital, Nichinan, Japan., Ishizaki J; Aisenkai Nichinan Hospital, Nichinan, Japan., Maeda K; Miyakonojo Medical Center, Miyakonojo, Japan., Nakai M; Clinical Research Support Center, University of Miyazaki Hospital, Miyazaki, Japan., Yamashita K; Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan., Kubuki Y; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Shimoda K; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. kshimoda@med.miyazaki-u.ac.jp.

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 722-727. Date of Electronic Publication: 2024 Mar 08.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Receptor, Fibroblast Growth Factor, Type 1*/genetics , Chromosomes, Human, Pair 8*/genetics , Translocation, Genetic*, Humans ; Japan/epidemiology ; Male ; Female ; Middle Aged ; Prevalence ; Aged ; Adult ; Cohort Studies ; Lymphoma/genetics ; Lymphoma/epidemiology ; In Situ Hybridization, Fluorescence

المؤلفون: Usuki K; Department of Hematology, NTT Medical Center Tokyo, 5-9-22 Higashi-Gotanda, Shinagawa-Ku, Tokyo, 141-8625, Japan. kensuke.usuki@gmail.com., Miyamoto T; Department of Hematology, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan., Yamauchi T; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyusyu University, Fukuoka, Japan., Ando K; Department of Hematology and Onclogy, Tokai University School of Medicine, Isehara, Kanagawa, Japan.; Department of Hematology, Hiroshima University School of Medicine, Hiroshima, Japan., Ogawa Y; Department of Hematology and Onclogy, Tokai University School of Medicine, Isehara, Kanagawa, Japan., Onozawa M; Department of Hematology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan., Yamauchi T; Department of Hematology and Oncology, University of Fukui, Fukui, Japan., Kiyoi H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan., Yokota A; Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan., Ikezoe T; Department of Hematology, Fukushima Medical University, Fukushima, Japan., Katsuoka Y; Department of Hematology, National Hospital Organization Sendai Medical Center, Sendai, Miyagi, Japan., Takada S; Department of Hematology, Saiseikai Maebashi Hospital, Maebashi, Gunma, Japan., Aotsuka N; Department of Hematology and Oncology, Japanese Red Cross Society Narita Hospital, Narita, Chiba, Japan., Morita Y; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Sayama, Osaka, Japan., Ishikawa T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan., Asada N; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan., Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Hokkaido, Japan., Dohi A; Clinical Development Department, Nippon Shinyaku Co., Ltd, Kyoto, Japan., Morimoto K; Data Science Depertment, Nippon Shinyaku Co., Ltd, Kyoto, Japan., Imai S; Drug Metabolism and Pharmacokinetics Research Department, Nippon Shinyaku Co., Ltd, Kyoto, Japan., Kishimoto U; Clinical Development Department, Nippon Shinyaku Co., Ltd, Kyoto, Japan., Akashi K; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyusyu University, Fukuoka, Japan., Miyazaki Y; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.

مؤلفون مشاركون: Study Group for NS-87/CPX-351

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 647-659. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Daunorubicin*/administration & dosage , Daunorubicin*/pharmacokinetics , Cytarabine*/administration & dosage , Cytarabine*/pharmacokinetics , Leukemia, Myeloid, Acute*/drug therapy , Liposomes* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/pharmacokinetics , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage, Humans ; Middle Aged ; Aged ; Male ; Female ; Japan ; Treatment Outcome ; Asian People ; East Asian People

المؤلفون: Shibayama H; Department of Hematology, NHO Osaka National Hospital, 2-1-14 Hoenzaka Chuo-ku, Osaka City, Osaka, 540-0006, Japan. shibayama.hirohiko.ec@mail.hosp.go.jp.; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan. shibayama.hirohiko.ec@mail.hosp.go.jp., Itagaki M; Department of Hematology, Hiroshima Red Cross Hospital, Hiroshima, Japan., Handa H; Department of Hematology, Gunma University, Gunma, Japan., Yokoyama A; Department of Hematology, NHO Tokyo Medical Center, Tokyo, Japan., Saito A; Department of Hematology, NHO Shibukawa Medical Center, Gunma, Japan., Kosugi S; Department of Hematology, Toyonaka Municipal Hospital, Osaka, Japan., Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Hokkaido, Japan., Yoshimitsu M; Department of Hematology and Rheumatology, Kagoshima University, Kagoshima, Japan., Tanaka Y; Department of Hematology, Shinko Hospital, Hyogo, Japan., Kurahashi S; Department of Hematology and Oncology, Toyohashi Municipal Hospital, Aichi, Japan., Fuchida SI; Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan., Iino M; Department of Hematology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan., Shimizu T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Moriuchi Y; Department of Hematology, Sasebo City General Hospital, Nagasaki, Japan., Toyama K; Department of Hematology, Fujioka General Hospital, Gunma, Japan., Mitani K; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Tsukune Y; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan., Kada A; Clinical Research Center, NHO Nagoya Medical Center, Aichi, Japan., Tamura H; Division of Diabetes, Endocrinology and Hematology, Department of Internal Medicine, Dokkyo Medical University Saitama Medical Center, Saitama, Japan., Abe M; Department of Hematology, Kawashima Hospital, Tokushima, Japan., Iwasaki H; Department of Hematology, NHO Kyushu Medical Center, Fukuoka, Japan., Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefecture University of Medicine, Kyoto, Japan., Takamatsu H; Department of Hematology, Kanazawa University, Kanazawa, Japan., Sunami K; Department of Hematology, NHO Okayama Medical Center, Okayama, Japan., Kizaki M; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Ishida T; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Saito T; Clinical Research Center, NHO Nagoya Medical Center, Aichi, Japan., Matsumura I; Department of Hematology and Rheumatology, Kindai University, Osaka, Japan., Akashi K; Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan., Iida S; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, 1 Kawasumi, Mizuho-Cho, Mizuho-ku, Nagoya City, Aichi, 467-8601, Japan. iida@med.nagoya-cu.ac.jp.

المصدر: International journal of hematology [Int J Hematol] 2024 Jun; Vol. 119 (6), pp. 707-721. Date of Electronic Publication: 2024 Mar 29.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Plasma Cell*/therapy, Humans ; Prospective Studies ; Aged ; Female ; Middle Aged ; Male ; Japan ; Transplantation, Autologous ; Prognosis ; Survival Rate ; Adult ; Hematopoietic Stem Cell Transplantation ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Multiple Myeloma/therapy ; Multiple Myeloma/mortality ; Multiple Myeloma/drug therapy ; East Asian People

المؤلفون: Suda T; Department of Medicine, Medical University of South Carolina, Charleston, USA. sudato@keio.jp.

المصدر: International journal of hematology [Int J Hematol] 2024 May; Vol. 119 (5), pp. 473-475. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Historical Article; Biography; Journal Article; Editorial

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Hematology*/history, History, 20th Century ; History, 21st Century ; Humans ; Japan

المؤلفون: Ishimura M; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. ischii-pediatr@kyudai.jp., Eguchi K; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan., Sonoda M; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan., Tanaka T; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan., Shiraishi A; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan., Sakai Y; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan., Yasumi T; Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan., Miyamoto T; Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan., Voskoboinik I; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Hashimoto K; Department of Pediatrics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan., Matsumoto S; Department of Pediatrics, Faculty of Life Science, Kumamoto University, Kumamoto, Japan., Ozono S; Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Fukuoka, Japan., Moritake H; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Takada H; Department of Child Health, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan., Ohga S; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.

المصدر: International journal of hematology [Int J Hematol] 2024 May; Vol. 119 (5), pp. 592-602. Date of Electronic Publication: 2024 Mar 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphohistiocytosis, Hemophagocytic*/therapy , Lymphohistiocytosis, Hemophagocytic*/diagnosis , Lymphohistiocytosis, Hemophagocytic*/etiology , Hematopoietic Stem Cell Transplantation* , Perforin*/genetics, Humans ; Japan ; Infant ; Female ; Male ; Infant, Newborn ; Treatment Outcome ; Child, Preschool ; Etoposide/therapeutic use ; Etoposide/administration & dosage

المؤلفون: Seki Y; Department of Hematology, Niigata University Medical and Dental Hospital, Chuoku Asahimachi-Dori 1, Niigata, 951-8520, Japan. y-seki@med.niigata-u.ac.jp.

المصدر: International journal of hematology [Int J Hematol] 2024 May; Vol. 119 (5), pp. 505-515. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Practice Guidelines as Topic* , Neoplasms*/therapy , Anticoagulants*/therapeutic use, Humans ; Japan ; Thrombosis/prevention & control ; Thrombosis/etiology ; Heparin, Low-Molecular-Weight/therapeutic use